New drug developed in Singapore could give eczema sufferers complete relief from symptoms

Around 13 per cent of Singapore's population suffers from eczema. PHOTO: ST FILE
New: Gift this subscriber-only story to your friends and family

SINGAPORE - A new drug currently being developed by local biotech company Aslan Pharmaceuticals may be able to provide those with eczema complete relief from their symptoms.

The company announced the enrolment of the first patient in its clinical trials on Tuesday (Oct 22).

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's WhatsApp Channel and get the latest news and must-reads.